期刊文献+

术中使用地塞米松对经皮肾镜术后全身炎症反应综合征影响的回顾性研究 被引量:3

Retrospective analysis for the effect of Dexamethasone on systemic inflammatory response syndrome after percutaneous nephrolithotomy
原文传递
导出
摘要 目的探讨地塞米松对经皮肾镜碎石取石术(PCNL)术后全身炎症反应综合征(SIRS)的影响。方法本研究回顾性收集了2011年1月到2015年3月在我院泌尿外科诊断泌尿系结石并行PCNL的患者病例资料486例,经排除最终纳入369例患者进行数据分析,并根据术中是否使用地塞米松分为两组,对比术后SIRS的发生率及其他预后指标。结果(1)纳入地塞米松组[DEX(+)组]有209例患者,非地塞米松组[DEX(–)]组有160例患者,两组患者术前基线临床资料差异无统计学意义(P>0.05);(2)术中情况对比,DEX(+)组的手术时间更长(106±74)min vs(81±58)min,P<0.001);需要使用血管活性药物的比例更高(22.5%vs 8.8%,P<0.001),其他指标如输血比例和经皮通道大小两组差异无统计学意义(P>0.05);(3)主要结局指标:两组发热的发生率、SIRS的发生率和发生SIRS的严重程度差异无统计学意义(P>0.05);(4)次要结局指标:DEX(+)组低血压发生率更高(14.8%vs 7.5%,P=0.03),血红蛋白下降水平更大[(11.6±2.0)g/L vs(8.0±2.3)g/L,P<0.001)],其他指标如术后肾功能变化和住院时间差异无统计学意义。结论术中使用地塞米松对PCNL术后SIRS的发生未提示有预防作用,仍需要更多的研究进一步验证。 Objective To explore the effect of Dexamethasone on systemic inflammatory response syndrome(SIRS)after percutaneous nephrolithotomy(PCNL)Methods There were 486 patients diagnosed with renal calculi and received PCNL in the Third Affiliated Hospital,Sun Yat-sen University from January 2011 to March 2015.After exclusion,369 cases were included in the statistical analysis.And the patients were divided into two groups according to whether Dexamethasone was used during the operation.The incidence of fever and SIRS,and the data of other prognostic indicators were recorded.Results There were 209 cases in the group Dexamethasone DEX(+),160 cases in the other group DEX(–),there was no significant different between two groups about the baseline indicators(P>0.05).The operation time of group DEX(+)was longer than group DEX(–)[(106±74)min vs(81±58)min,P<0.001],the proportion of patients required to use of vasoactive drugs was higher in group DEX(+)(22.5%vs 8.8%,P<0.001),there were no significant difference in the need to transfusion or the size of between the two groups tube(P>0.05).The primary outcomes:there were no significant difference in the incidence of SIRS,fever,score of SIRS(P>0.05);The secondary outcomes:The incidence of postoperative hypotension was higher in group DEX(+)(14.8%vs 7.5%,P=0.03),the reduction of HGB level in group DEX(+)was more than group DEX(–)[(11.6±2.0)g/L vs(8.0±2.3)g/L,P<0.001],there were no significant difference in postoperative renal function and length of hospital stay between the two groups(P>0.05).Conclusions It dose not suggest that the intraoperative use of Dexamethasone has a preventive effect on the occurrence of SIRS after PCNL,however,further studies are needed to verify it.
作者 程楠 谭芳 胡静萍 李响 龚楚链 周少丽 Cheng Nan;Tan Fang;Hu Jingping;Li Xiang;Gong Chulian;Zhou Shaoli(Department of Anesthesiology,the Third Affiliated Hospital,Sun Yat-sen University,Guangzhou 510630,China;Department of Anesthesiology,the Seven Affiliated Hospital,Sun Yat-sen University,Shenzhen 518107,China)
出处 《中华腔镜泌尿外科杂志(电子版)》 2020年第4期274-278,共5页 Chinese Journal of Endourology(Electronic Edition)
基金 中山大学临床医学研究“5010”计划项目(2015006)。
关键词 经皮肾镜 炎症反应综合征 地塞米松 预防 回顾性研究 PCNL SIRS Dexamethasone Prevent Retrospective analysis
  • 相关文献

参考文献5

二级参考文献46

  • 1叶章群.泌尿系结石研究现况与展望[J].中华实验外科杂志,2005,22(3):261-262. 被引量:268
  • 2冉蓉,张美兰,印春铭.经皮肾镜碎石术中灌流液吸收及对血循环和血生化的影响[J].辽宁中医学院学报,2006,8(3):83-83. 被引量:38
  • 3唐帅,王玲,黄宇光.围术期轻度低体温的并发症及防治措施[J].基础医学与临床,2007,27(10):1161-1164. 被引量:17
  • 4Michel MS, Trojan L, Rassweiler JJ. Complications in percutaneous nephrolithotomy[J]. Eur Urol, 2007, 51 (4): 899-906.
  • 5Koras O, Bozkurt IH, Yonguc T, et al. Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study [J]. Urolithiasis, 2014, [Epub ahead of print].
  • 6Lojanapiwat B, Kitirattrakarn P. Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy[J]. Urol Int, 2011, 86(4): 448-452.
  • 7Moslemmi MK, Mousavi-Bahar SI-I, Abedinzadeh M. The feasibility of regional anesthesia in the percutaneous nephrolithotomy with supracostal approach and its comparison with general anesthesia [J]. Urolithiasis, 2013, 41(1): 53-57.
  • 8Cadeddu JA, Chen R, Bishoff J, et al. Clinical significance of fever after percutaneous nephrolithotomy[J]. Urolog, 1998, 52(1): 48-50.
  • 9Deitch EA, Goodman ER. Prevention of multiple organ failure [J]. Surg Clin North Am, 1999, 79(6): 1471-1488.
  • 10Kimura H,?Okada O,?Tanabe N, et al. Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension[J]. Am J Respir Crit Care Med, 2001, 164(2): 319-324.

共引文献59

同被引文献19

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部